Topic Archives: Cancer

Identifying Manward’s teased “$5 Cancer Killer That’s Headed to $50”

Andrew Snyder has been on the editorial team of a bunch of different Agora-affiliated newsletters over the years, and is now helming his own little offshoot called Manward Press — a publishing imprint that aims to helm men reach “true fulfillment” by focusing on “Liberty, Know-how and connections” … though, of course, to sell newsletters […]

Answers: “The Most Disruptive Biotech Discovery of 2015-Confirmed Live: October 19th, 5:15 pm”

That’s a mysterious headline, right? The pitch we’re looking at today is from Dave Lashmet at Stansberry, who’s selling his Stansberry Venture newsletter for $5,000 — and the carrot he’s dangling to get you to subscribe is this “most disruptive biotech discovery” … which, it turns out, is a form of radiation therapy that, in […]

What’s Happening in Cancer Treatment? Are We Making Progress, or Are We Stuck?

Today we’re sharing another piece from our medical contributor, “Doc Gumshoe” — we have added the stock tickers to the companies he mentions for your researching convenience, but this survey of the state of cancer research — which will hopefully be good background help to folks trying to understand the basic science behind pitches for […]

Comments

  • Breaking news yesterday in a journal that details striking results in a 8 year Phase III trial vaccine to halt brain can...

  • old expression it takes money to make money like our beloved President and family. If not for Fred Donald's dad he woul...

  • $AllCancerTickers $NoTicker https://www.newscientist.com/article/2164903-newly-discovered-human-organ-may-help-expla...

  • Thank you Dr KSS, the articles keep getting better and better. Great information. Long $Apto and looking forward to havi...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.